<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>ETHNOPHARMACOLOGICAL RELEVANCE: Rhodiola species are traditionally used as tonics and stimulants to treat asthenia, suggesting their possible regulatory effect on energy metabolism </plain></SENT>
<SENT sid="1" pm="."><plain>Clinical trials have demonstrated their <z:chebi fb="105" ids="17234">glucose</z:chebi>-lowering effect in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>AIM OF THE STUDY: To examine the effects of Rhodiola on <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism in the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIALS AND METHODS: <z:chebi fb="3" ids="16646">Zucker</z:chebi> diabetic fatty (ZDF) rats were treated with Rhodiola crenulata root (RCR) powder (100 and 500 mg/kg, by gavage, once daily for 4 weeks) </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, the effects of RCR on <z:chebi fb="27" ids="17992">sucrose</z:chebi>-induced <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> in mice and olive oil-induced <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> in rats were also examined </plain></SENT>
<SENT sid="5" pm="."><plain>Biochemical variables were determined enzymatically or by ELISA </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In ZDF rats, RCR treatment decreased the increased plasma insulin and <z:chebi fb="0" ids="17855">triglyceride</z:chebi> concentrations at baseline, the index of the homeostasis model assessment of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> (HOMA-IR) and excessive hepatic <z:chebi fb="0" ids="17855">triglyceride</z:chebi> accumulation </plain></SENT>
<SENT sid="7" pm="."><plain>This treatment also inhibited abnormal increases in plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin concentrations during oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, RCR reversed the increased adipose <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> index, and accelerated the decline of plasma concentrations of non-esterified fatty acids after exogenous <z:chebi fb="105" ids="17234">glucose</z:chebi> stimulation </plain></SENT>
<SENT sid="9" pm="."><plain>However, RCR minimally affected <z:chebi fb="27" ids="17992">sucrose</z:chebi>-induced <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> in mice and olive oil-induced <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> in rats </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: The present results demonstrate that RCR treatment improves metabolic derangements in animal model of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>Our findings may provide new pharmacological basis of therapeutics for the adaptogenic plants to treat metabolic derangements-associated disorders, such as asthenia </plain></SENT>
</text></document>